NCT05725291
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05725291
Title AMT-116 in Patients With Selected Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Beijing Immunochina Medical Science & Technology Co., Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Sarah Cannon Research Institute NOT_YET_RECRUITING Denver Colorado 80218 United States Details
Mary Crowley Cancer Research Centers RECRUITING Dallas Texas 75230 United States Details
University of California San Francisco Cancer Center NOT_YET_RECRUITING San Francisco California 94115 American Samoa Details
Carolina BioOncology Institute, LLC RECRUITING Cary North Carolina 28078 American Samoa Details
Macquarie University Hospital RECRUITING Sydney New South Wales 2109 Australia Details
ICON Cancer Centre RECRUITING Brisbane Queensland Australia Details
Southern Oncology Clinical Research Unit RECRUITING Adelaide South Australia 5042 Australia Details
Alfred Hospital RECRUITING Victoria Park Victoria 3004 Australia Details
Austin Health RECRUITING Victoria Park Victoria 3084 Australia Details
Cabrini Hospital RECRUITING Victoria Park Victoria 3144 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field